Ledger.Open graph →

SEC Form D · filed February 21, 2023

VistaGen Therapeutics, Inc

Offering

$2.8M

Sold

—

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

South San Francisco, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jerrold D. Dotson · South San Francisco, CAExec Jon S. Saxe · South San Francisco, CADirector Shawn K. Singh · South San Francisco, CAExec · Director Jerry B. Gin · South San Francisco, CADirector Ann M. Cunningham · South San Francisco, CADirector Mark W. Brooker · Houston, TXDirector Asia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · Director Earl Webb · Chicago, ILExec Joanne M. Curley · South San Francisco, CADirector Reid G. Adler · South San Francisco, CAExec Margaret M. Fitzpatrick · South San Francisco, CADirector Mary L. Rotunno · South San Francisco, CADirector Ishaan Nerurkar · Berkeley, CADirector Colton Jang · Berkeley, CAExec Paul G. Roess · Chattanooga, TNExec · Director Joanne M. Curley · South San Francisco, CADirector Jerry B. Gin · South San Francisco, CADirector Ann M. Cunningham · South San Francisco, CADirector Reid G. Adler · South San Francisco, CAExec Margaret M. Fitzpatrick · South San Francisco, CADirector Mary L. Rotunno · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗